UNLIMITED

MoneyWeek

Know your options

Ask any wealth manager, and they will tell you that the key to building wealth is to remain invested throughout each market cycle and ignore short-term volatility. Yes, markets wax and wane, but the way to cope with this is to diversify your assets and occasionally rotate by sector, geography or asset class.

The accepted wisdom as you get older is to move away from equities and into bonds. While you will forego the higher returns typically afforded by equities, you’ll sleep better at night knowing your money is in relatively less volatile instruments and will pay you a known income.

So is that it, or is there anything else you can do with at least a part of your overall portfolio that can help achieve the investing trinity of wealth preservation, capital growth and income?

One answer could be to use derivatives as an overlay to your portfolio. However, the very mention of this word often provokes a visceral reaction from investors because of derivatives’ leverage and complexity.

“Derivatives” is a catch-all term for any financial instrument that derives its price from an underlying asset such as equities, bonds, currencies or commodities.

You’re reading a preview, subscribe to read more.

More from MoneyWeek

MoneyWeek3 min read
MoneyWeek’s Comprehensive Guide To This Week’s Share Tips
The TelegraphBHP recently slashed its dividend by 14% but still offers a 5.3% yield, higher than the FTSE 100 index’s 3.7%. The mining giant aims to pay out at least 50% of profits to investors while investing in operations. BHP is expected to benefi
MoneyWeek1 min read
Founders Will Pay More On Sales
Rising capital gains tax (CGT) rates will mean higher bills for many business owners who sell their companies. Prior to the Budget, someone selling a business paid 20% CGT on most of their profits. From 30 October, this increased to 24%. Business ass
MoneyWeek1 min read
A German view
Germany’s BioNTech built up a net cash position of €17bn thanks to its mRNA Covid vaccine, says Wirtschaftswoche. That provided plenty of money to fund the development of new treatments. One promising example is BNT327, a bispecific antibody (an arti

Related Books & Audiobooks